Active Clearance Technology (ACT) Registry
NCT02682849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2020-10-29
Summary
The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technology™ (ACT) System in the management of blood evacuation after cardiac surgery.
Conditions
- Retained Blood Syndrome
Sponsors & Collaborators
-
John M. Stulak
lead OTHER
Principal Investigators
-
John Stulak, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-10
- Primary Completion
- 2018-05-31
- Completion
- 2020-03-31
Countries
- United States
Study Locations
More Related Trials
-
Platelet Activity in Vascular Surgery and Cardiovascular Events
NCT02106429 ·Status: COMPLETED
-
Fibrinogen Early In Severe Trauma StudY II
NCT05449834 ·Status: RECRUITING ·Phase: PHASE3
-
Determination of Fibrin Activity in Plasma on STA-R® Prototype
NCT02856789 ·Status: COMPLETED
-
Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation
NCT01563458 ·Status: COMPLETED ·Phase: PHASE2
-
"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
NCT00214656 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer
NCT01848431 ·Status: WITHDRAWN
-
Adjusted Fibrinogen Replacement Strategy
NCT03444324 ·Status: COMPLETED ·Phase: PHASE3
-
Fibrinogen in Liver Transplant Subjects
NCT06764927 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
NCT06109155 ·Status: RECRUITING ·Phase: PHASE4
-
Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial
NCT02269449 ·Status: UNKNOWN ·Phase: NA
-
Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
NCT00029315 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Activated Recombinant FVII in Spinal Surgery
NCT00102037 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Haemostatic Agent Purabond in ENT TORS
NCT05405907 ·Status: COMPLETED
-
Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions
NCT06222866 ·Status: RECRUITING
-
START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism
NCT01291290 ·Status: UNKNOWN ·Phase: NA
-
INR-Triggered Transfusion In GI Bleeders From ER
NCT01461889 ·Status: TERMINATED ·Phase: PHASE3
-
The DIEP-Flap as a Model of Ischemia-Reperfusion
NCT00482469 ·Status: COMPLETED
-
Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
NCT06891131 ·Status: RECRUITING
-
Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
NCT02637427 ·Status: COMPLETED ·Phase: PHASE3
-
Fibrinogen in Liver Transplant
NCT07265843 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
IV Tranexamic Acid Prior to Hysterectomy
NCT02911831 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease
NCT00071032 ·Status: COMPLETED ·Phase: PHASE3
-
N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection
NCT01223326 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery
NCT03425799 ·Status: TERMINATED ·Phase: PHASE3
-
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
NCT02094118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2